 |
PDBsum entry 1s1f
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1s1f
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.14.19.69
- biflaviolin synthase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
2 flaviolin + 2 reduced [2Fe-2S]-[ferredoxin] + O2 + H+ = 3,3'-biflaviolin + 2 oxidized [2Fe-2S]-[ferredoxin] + 2 H2O
|
|
2.
|
2 flaviolin + 2 reduced [2Fe-2S]-[ferredoxin] + O2 + H+ = 3,8'-biflaviolin + 2 oxidized [2Fe-2S]-[ferredoxin] + 2 H2O
|
|
 |
 |
 |
 |
 |
2
×
flaviolin
Bound ligand (Het Group name = )
matches with 44.44% similarity
|
+
|
2
×
reduced [2Fe-2S]-[ferredoxin]
|
+
|
O2
|
+
|
H(+)
|
=
|
3,3'-biflaviolin
Bound ligand (Het Group name = )
matches with 40.38% similarity
|
+
|
2
×
oxidized [2Fe-2S]-[ferredoxin]
|
+
|
2
×
H2O
|
|
 |
 |
 |
 |
 |
2
×
flaviolin
Bound ligand (Het Group name = )
matches with 44.44% similarity
|
+
|
2
×
reduced [2Fe-2S]-[ferredoxin]
|
+
|
O2
|
+
|
H(+)
|
=
|
3,8'-biflaviolin
Bound ligand (Het Group name = )
matches with 40.38% similarity
|
+
|
2
×
oxidized [2Fe-2S]-[ferredoxin]
|
+
|
2
×
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
280:11599-11607
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Binding of two flaviolin substrate molecules, oxidative coupling, and crystal structure of Streptomyces coelicolor A3(2) cytochrome P450 158A2.
|
|
B.Zhao,
F.P.Guengerich,
A.Bellamine,
D.C.Lamb,
M.Izumikawa,
L.Lei,
L.M.Podust,
M.Sundaramoorthy,
J.A.Kalaitzis,
L.M.Reddy,
S.L.Kelly,
B.S.Moore,
D.Stec,
M.Voehler,
J.R.Falck,
T.Shimada,
M.R.Waterman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cytochrome P450 158A2 (CYP158A2) is encoded within a three-gene operon
(sco1206-sco1208) in the prototypic soil bacterium Streptomyces coelicolor
A3(2). This operon is widely conserved among streptomycetes. CYP158A2 has been
suggested to produce polymers of flaviolin, a pigment that may protect microbes
from UV radiation, in combination with the adjacent rppA gene, which encodes the
type III polyketide synthase, 1,3,6,8-tetrahydroxynaphthalene synthase.
Following cloning, expression, and purification of this cytochrome P450, we have
shown that it can produce dimer and trimer products from the substrate flaviolin
and that the structures of two of the dimeric products were established using
mass spectrometry and multiple NMR methods. A comparison of the x-ray structures
of ligand-free (1.75 angstroms) and flaviolin-bound (1.62 angstroms) forms of
CYP158A2 demonstrates a major conformational change upon ligand binding that
closes the entry into the active site, partly due to repositioning of the F and
G helices. Particularly interesting is the presence of two molecules of
flaviolin in the closed active site. The flaviolin molecules form a quasi-planar
three-molecule stack including the heme of CYP158A2, suggesting that oxidative
C-C coupling of these phenolic molecules leads to the production of flaviolin
dimers.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 7.
FIG. 7. Stereoview of the hydrogen-bonding network among
Arg71, Arg288, and Leu293 and ordered waters and the two
flaviolin molecules in the CYP158A2 active site. The side chain
atoms and flaviolin atoms are rendered as stick figures. Water
molecules are displayed as red spheres. Potential hydrogen bonds
are dotted green lines.
|
 |
Figure 8.
FIG. 8. Proposed diradical mechanism for formation of the
flaviolin dimers by CYP158A2.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
11599-11607)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.T.Lee,
E.C.Glazer,
R.F.Wilson,
C.D.Stout,
and
D.B.Goodin
(2011).
Three clusters of conformational States in p450cam reveal a multistep pathway for closing of the substrate access channel .
|
| |
Biochemistry,
50,
693-703.
|
 |
|
|
|
|
 |
D.C.Lamb,
L.Lei,
B.Zhao,
H.Yuan,
C.J.Jackson,
A.G.Warrilow,
T.Skaug,
P.J.Dyson,
E.S.Dawson,
S.L.Kelly,
D.L.Hachey,
and
M.R.Waterman
(2010).
Streptomyces coelicolor A3(2) CYP102 protein, a novel fatty acid hydroxylase encoded as a heme domain without an N-terminal redox partner.
|
| |
Appl Environ Microbiol,
76,
1975-1980.
|
 |
|
|
|
|
 |
L.E.Thornton,
S.G.Rupasinghe,
H.Peng,
M.A.Schuler,
and
M.M.Neff
(2010).
Arabidopsis CYP72C1 is an atypical cytochrome P450 that inactivates brassinosteroids.
|
| |
Plant Mol Biol,
74,
167-181.
|
 |
|
|
|
|
 |
T.C.Pochapsky,
S.Kazanis,
and
M.Dang
(2010).
Conformational plasticity and structure/function relationships in cytochromes P450.
|
| |
Antioxid Redox Signal,
13,
1273-1296.
|
 |
|
|
|
|
 |
Y.T.Lee,
R.F.Wilson,
I.Rupniewski,
and
D.B.Goodin
(2010).
P450cam visits an open conformation in the absence of substrate.
|
| |
Biochemistry,
49,
3412-3419.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.G.Denisov,
D.J.Frank,
and
S.G.Sligar
(2009).
Cooperative properties of cytochromes P450.
|
| |
Pharmacol Ther,
124,
151-167.
|
 |
|
|
|
|
 |
L.H.Xu,
S.Fushinobu,
H.Ikeda,
T.Wakagi,
and
H.Shoun
(2009).
Crystal structures of cytochrome P450 105P1 from Streptomyces avermitilis: conformational flexibility and histidine ligation state.
|
| |
J Bacteriol,
191,
1211-1219.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Belin,
M.H.Le Du,
A.Fielding,
O.Lequin,
M.Jacquet,
J.B.Charbonnier,
A.Lecoq,
R.Thai,
M.Courçon,
C.Masson,
C.Dugave,
R.Genet,
J.L.Pernodet,
and
M.Gondry
(2009).
Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.
|
| |
Proc Natl Acad Sci U S A,
106,
7426-7431.
|
 |
|
|
|
|
 |
P.F.Widboom,
and
S.D.Bruner
(2009).
Complex oxidation chemistry in the biosynthetic pathways to vancomycin/teicoplanin antibiotics.
|
| |
Chembiochem,
10,
1757-1764.
|
 |
|
|
|
|
 |
A.N.Holding,
and
J.B.Spencer
(2008).
Investigation into the mechanism of phenolic couplings during the biosynthesis of glycopeptide antibiotics.
|
| |
Chembiochem,
9,
2209-2214.
|
 |
|
|
|
|
 |
B.Zhao,
X.Lin,
L.Lei,
D.C.Lamb,
S.L.Kelly,
M.R.Waterman,
and
D.E.Cane
(2008).
Biosynthesis of the sesquiterpene antibiotic albaflavenone in Streptomyces coelicolor A3(2).
|
| |
J Biol Chem,
283,
8183-8189.
|
 |
|
|
|
|
 |
D.Hamdane,
H.Zhang,
and
P.Hollenberg
(2008).
Oxygen activation by cytochrome P450 monooxygenase.
|
| |
Photosynth Res,
98,
657-666.
|
 |
|
|
|
|
 |
E.M.Isin,
and
F.P.Guengerich
(2008).
Substrate binding to cytochromes P450.
|
| |
Anal Bioanal Chem,
392,
1019-1030.
|
 |
|
|
|
|
 |
G.A.Schoch,
J.K.Yano,
S.Sansen,
P.M.Dansette,
C.D.Stout,
and
E.F.Johnson
(2008).
Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid.
|
| |
J Biol Chem,
283,
17227-17237.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Ouellet,
L.M.Podust,
and
P.R.de Montellano
(2008).
Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.
|
| |
J Biol Chem,
283,
5069-5080.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Ding,
W.H.Seufert,
Z.Q.Beck,
and
D.H.Sherman
(2008).
Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
|
| |
J Am Chem Soc,
130,
5492-5498.
|
 |
|
|
|
|
 |
Y.Wada,
M.Mitsuda,
Y.Ishihara,
M.Watanabe,
M.Iwasaki,
and
S.Asahi
(2008).
Important amino acid residues that confer CYP2C19 selective activity to CYP2C9.
|
| |
J Biochem,
144,
323-333.
|
 |
|
|
|
|
 |
A.W.Munro,
H.M.Girvan,
and
K.J.McLean
(2007).
Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily.
|
| |
Nat Prod Rep,
24,
585-609.
|
 |
|
|
|
|
 |
F.P.Guengerich
(2007).
Mechanisms of cytochrome P450 substrate oxidation: MiniReview.
|
| |
J Biochem Mol Toxicol,
21,
163-168.
|
 |
|
|
|
|
 |
M.Makino,
H.Sugimoto,
Y.Shiro,
S.Asamizu,
H.Onaka,
and
S.Nagano
(2007).
Crystal structures and catalytic mechanism of cytochrome P450 StaP that produces the indolocarbazole skeleton.
|
| |
Proc Natl Acad Sci U S A,
104,
11591-11596.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
X.Pang,
F.Xu,
S.G.Bell,
D.Guo,
L.L.Wong,
and
Z.Rao
(2007).
Purification, crystallization and preliminary crystallographic analysis of cytochrome P450 203A1 from Rhodopseudomonas palustris.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
63,
342-345.
|
 |
|
|
|
|
 |
D.C.Lamb,
F.P.Guengerich,
S.L.Kelly,
and
M.R.Waterman
(2006).
Exploiting Streptomyces coelicolor A3(2) P450s as a model for application in drug discovery.
|
| |
Expert Opin Drug Metab Toxicol,
2,
27-40.
|
 |
|
|
|
|
 |
M.J.de Groot
(2006).
Designing better drugs: predicting cytochrome P450 metabolism.
|
| |
Drug Discov Today,
11,
601-606.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |